title: [Mendes Da Costa erythrokeratoderma variabilis. Effect of RO 10-9359 (Tigason)].
authors.affiliation: Unité de Dermatologie Pédiatrique, Hôpital Trousseau, Paris.
authors.forename: M
authors.initials: M
authors.lastname: Larrègue
authors.forename: J M
authors.initials: JM
authors.lastname: Bressieux
authors.forename: A
authors.initials: A
authors.lastname: Titi
authors.forename: G
authors.initials: G
authors.lastname: De Voel
authors.forename: C
authors.initials: C
authors.lastname: Bieder
authors.forename: N
authors.initials: N
authors.lastname: Lhuillier
authors.forename: I
authors.initials: I
authors.lastname: Bachour
mesh_terms: D000328:Adult; D003873:Dermatitis, Exfoliative / Q000188:drug therapy*; D005050:Etretinate / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007642:Keratosis / Q000188:drug therapy*; D012008:Recurrence
chemical_list: D005050:Etretinate
vernacular_title: Erythrokératodermie variable de Mendes Da Costa. Action du RO 10-9359 (Tigason).